Allscripts Healthcare Solutions (NASDAQ:MDRX) issued an update on its FY19 earnings guidance on Thursday morning. The company provided EPS guidance of $0.65-0.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.68. Allscripts Healthcare Solutions also updated its FY 2019 guidance to $0.65-0.70 EPS.
Shares of NASDAQ:MDRX traded down $0.43 during trading on Friday, reaching $9.73. The stock had a trading volume of 3,919,772 shares, compared to its average volume of 1,951,054. Allscripts Healthcare Solutions has a one year low of $8.54 and a one year high of $14.97. The firm has a market cap of $1.59 billion, a P/E ratio of 17.69, a P/E/G ratio of 1.95 and a beta of 1.30. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a 50-day moving average of $10.97.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Thursday, August 8th. The software maker reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The business had revenue of $444.50 million for the quarter, compared to analysts’ expectations of $449.03 million. Allscripts Healthcare Solutions had a net margin of 20.60% and a return on equity of 6.92%. The company’s revenue was up .7% compared to the same quarter last year. During the same period last year, the business earned $0.18 EPS. As a group, analysts forecast that Allscripts Healthcare Solutions will post 0.48 earnings per share for the current year.
MDRX has been the subject of several research analyst reports. Zacks Investment Research raised shares of Allscripts Healthcare Solutions from a sell rating to a hold rating in a research report on Wednesday, April 24th. Cantor Fitzgerald reaffirmed a hold rating and issued a $10.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Thursday, May 2nd. BidaskClub lowered shares of Allscripts Healthcare Solutions from a sell rating to a strong sell rating in a research report on Friday. Finally, ValuEngine lowered shares of Allscripts Healthcare Solutions from a hold rating to a sell rating in a research report on Friday, July 26th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $12.60.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
See Also: Tariff
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.